Elucid Bio Headquarters
Looking for information about Elucid Bio Headquarters? The links below have collected all the necessary data.
https://www.elucidbio.com/contact
Get in touch to learn more about Elucid Bioimaging and our products. We will get back to you shortly. [email protected]. Tel: +1-617-329-9487. 2 Park Plaza. Boston, MA 02116.
https://www.crunchbase.com/organization/elucid-bioimaging
Headquarters Regions Greater Boston Area, East Coast, New England; Founded Date 2013; Founders Andrew J. Buckler; Operating Status Active; Last Funding Type Series A; Also Known As Elucid; Legal Name Elucid Bioimaging Inc. Company Type For Profit; Contact Email [email protected]; Phone Number 617-329-9487Founded: 2013
https://www.elucidbio.com/about
Elucid is a Boston-based MedTech company advancing cardiovascular diagnostic imaging through machine learning. Put the power of today's AI to address atherosclerotic disease. Elucid Bioimaging is a Boston-based medical technology company focused on improving the accuracy, experience, and cost-effectiveness of diagnostic imaging by leveraging A.I.
https://globalhealthimpactfund.com/elucid-bio/
Aug 17, 2020 · Enabling Precision Medicine for Cardiovascular Disease. Elucid Bio is a Boston-based medical technology company using AI to provide physicians with a cost-effective means to optimize treatment decisions for patients with known or suspected cardiovascular disease. HEADQUARTERS. Boston, MA. SECTOR. Digital Health : Artificial Intelligence. FOUNDED.Estimated Reading Time: 1 min
https://www.biospace.com/article/releases/elucid-bioimaging-relocates-headquarters-to-downtown-boston/
Dec 12, 2019 · BOSTON--(BUSINESS WIRE)-- Elucid Bioimaging Inc. is pleased to announce it has relocated its headquarters to 2 Park Plaza in downtown Boston. “This move helps facilitate Elucid’s ongoing expansion and provides increased proximity to research institutes, provider partners, and technology talent,” said CEO Blake Richards.
http://cardiacvascularnews.com/elucid-bioimaging-relocates-headquarters-to-downtown-boston/
Dec 12, 2019 · BOSTON– ( BUSINESS WIRE )–Elucid Bioimaging Inc. is pleased to announce it has relocated its headquarters to 2 Park Plaza in downtown Boston. “This move helps facilitate Elucid’s ongoing expansion and provides increased proximity to research institutes, provider partners, and technology talent,” said CEO Blake Richards. Elucid is also pleased to announce the redesign and …Estimated Reading Time: 2 mins
https://www.elucidbio.com/news
Jul 06, 2020 · Boston-based medical technology company Elucid Bio, maker of the Food and Drug Administration (FDA)-cleared and CE-marked vascuCAP software, announced Wednesday, July 1, that its novel artificial intelligence (AI) technology demonstrated a significant improvement in accuracy of stroke prediction as compared to stenosis-based guidelines over a six-year time period.
https://www.linkedin.com/company/elucid-bioimaging-inc-
Elucid is a medical technology company leveraging machine intelligence to improve the accuracy, experience, and cost-effectiveness of vascular diagnostic imaging. Its groundbreaking product ...Employees: 25
https://www.crunchbase.com/organization/elucid-mhealth
Elucid mHealth is a medication technology company creating adherence monitoring tools and virtual health platform aimed at improving clinical trial efficiencies. Elucid's novel product, Pill Connect, provides trial organizers with real-time adherence data and missed dose prevention, new dose data, protocol control, engagement measurements and ...Founded: 2013
https://www.elucidbio.com/products
Elucid Bioimaging is a Boston-based medical technology company focused on improving the accuracy, experience, and cost-effectiveness of diagnostic imaging by leveraging A.I. Clinical Edition FDA-cleared & CE-marked arterial analysis software for clinical use
Have you found Elucid Bio Headquarters information?
On our site you can find many other information about headquarters of any company. Research information about other companies.
Related Pages:
|
Recently Added Pages:
|